# E-DRUG: Re: Drug and Therapeutics Committees (contd)

**URL:** <https://talk.edrugplus.org/t/e-drug-re-drug-and-therapeutics-committees-contd/3478>\
**Category:** e-drug\
**Created:** [September 15, 1998, 8:39pm UTC](https://talk.edrugplus.org/t/e-drug-re-drug-and-therapeutics-committees-contd/3478 "1998-09-15T20:39:24Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![richardl1951](https://avatars.discourse-cdn.com/v4/letter/r/b3f665/32.png) [@richardl1951](https://talk.edrugplus.org/u/richardl1951)\
**Post date:** [September 15, 1998, 8:39pm UTC](https://talk.edrugplus.org/t/e-drug-re-drug-and-therapeutics-committees-contd/3478/1 "1998-09-15T20:39:24Z")

</div>

E-drug: E-DRUG: Re: Drug and Therapeutics Committees (contd)  
----------------------------------------------------------

The message from Dr Shariff is very interesting as these ideas have been  
considered for DTC's in Zimbabwe but there are problems. The WHO indicators  
of drug use in health facilities are for out patients not inpatients and  
they do not work so well for inpatients. They are affected by disease mix  
and duration of admission.  
Reviewing how often the formulary is revised may be useful but if the  
committee meets every month and discusses changes would these count as new  
editions?  
Sending out news bulletins may be a measure of activity but unfortunately  
we know they do not correalate with changes in practice.

So I think we need to try other measures. My suggestions include:  
Frequency of D&T meetings, attendance rates, studies undertaken, success of  
interventions, changes in consumption of targetted drugs.

However we need to field test these indicators and so I think the proposed  
WHO manual will be very useful for these tests.

Richard Laing  
Associate Professor  
Department of International Health  
Boston University School of Public Health  
715 Albany St  
Boston MA 02118-2526  
Tel 617 414-1444  
Fax 617 414-1442 or 638-4476  
richardl@bu.edu

--  
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.  
Mail administrative requests to `majordomo@usa.healthnet.org'.  
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.
